Delivery Order SPE2DB24D1104-SPE2DB25FXZV5
Award Date
4/14/25
Potential Completion Date
4/15/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award with ID SPE2DB22D1017|SPE2DB25FF2BN was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,145.46 firm fixed-price delivery order is for the supply of 4566798406 VYVANSE 10 MG CAPSULE 100S, with a completion date of December 27, 2024. This award is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,908.04 firm fixed-price delivery order is for the supply of 4567059430 - VYVANSE 30 MG CAPSULE 100S, with a period of performance through January 28, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,783.60 firm fixed-price delivery order is for the supply of 4567558133 - VYVANSE 10 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of March 12, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, with an ID of SPE2DB20D1100|SPE2DB25FZ20U, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $2,784.96, is a delivery order for the supply of 4566529414 - VYVANSE 10 MG CAPSULE 100S. The contract has a firm fixed price and an ultimate completion date of November 25, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award, with the ID SPE2DX22D0010|SPE2D824FCC60, was issued by the Defense Logistics Agency's Medical Supply Chain to the prime contractor Amerisourcebergen Drug Corp. The $12,828.52 firm fixed-price delivery order is for the supply of VYVANSE CAPS 30MG, a pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,495.11 firm fixed-price delivery order is for the supply of 4566477213 VYVANSE 40 MG CAPSULE 100S. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,276.40, is for the supply of VYVANSE 50 MG CAPSULE 100S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 5, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,543.41 firm fixed-price delivery order is for the supply of 4,563,894,518 units of VYVANSE 20 MG CAPSULE 100S, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a...
This federal contract award, with ID SPE2DB20D1004|SPE2DB24FF8U7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,396.99 firm fixed-price delivery order is for the supply of 4564375487 VYVANSE 10 MG CAPSULE 100S. The contract has an ultimate completion date of April 24, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not designated with any set-aside...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FNJ00, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $5,978.80 Firm Fixed Price Delivery Order contract is for the supply of 4566265008 - VYVANSE 10 MG CAPSULE 100S. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...